1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form | Patent Number 09732053

US 09732053 B2
Application Number14902326
Publication NumberUS 20160289202 A1
Pendency3 years, 1 month, 17 days
Filled DateJun 30, 2014
Priority DateJun 30, 2014
Publication DateOct 6, 2016
Expiration DateJun 29, 2034
Inventor/ApplicantsRobert Ziegert-Knepper
Arthur Pichler
Verena Adamer
Andreas Hotter
ExaminesPALLAY, MICHAEL B
Art Unit1617
Technology Center1600
Assignments
Lek Pharmaceuticals D.d. Sandoz
Current
Lek Pharmaceuticals D.d. SandozNovartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.